BOGLE INVESTMENT MANAGEMENT L P /DE/ - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 128 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 7.96 and the average weighting 0.2%.

Quarter-by-quarter ownership
BOGLE INVESTMENT MANAGEMENT L P /DE/ ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$425,000
-6.2%
43,954
+10.9%
0.12%
+66.7%
Q2 2020$453,000
-79.5%
39,629
-81.4%
0.08%
-67.5%
Q1 2020$2,211,000
-41.9%
213,440
-7.9%
0.23%
-34.9%
Q4 2019$3,803,000
+32.6%
231,733
+7.3%
0.36%
+43.7%
Q3 2019$2,868,000
-44.1%
215,936
+9.9%
0.25%
-38.2%
Q4 2018$5,134,000
+8.5%
196,471
-4.7%
0.40%
+17.6%
Q3 2018$4,731,000
+75.0%
206,154
+45.3%
0.34%
+74.4%
Q2 2018$2,703,000
-30.8%
141,882
-38.8%
0.20%
-33.7%
Q1 2018$3,905,000
-20.7%
231,731
-28.5%
0.29%
-18.8%
Q4 2017$4,924,000
-22.0%
323,997
-8.1%
0.36%
-15.8%
Q3 2017$6,311,000
+548.6%
352,604
+407.1%
0.43%
+532.4%
Q1 2017$973,000
-86.5%
69,527
-84.6%
0.07%
-86.3%
Q4 2016$7,191,000
-18.3%
450,847
-14.8%
0.50%
-21.9%
Q3 2016$8,803,000
-10.7%
529,076
-12.8%
0.64%
-6.1%
Q1 2014$9,855,000
-14.8%
606,489
-35.0%
0.68%
-30.8%
Q4 2013$11,573,000
+75.2%
932,628
+54.6%
0.98%
+46.0%
Q3 2013$6,606,000
-15.9%
603,344
-37.9%
0.67%
-30.3%
Q2 2013$7,853,000971,9830.96%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q4 2017
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 1,532,000$27,423,0003.23%
Stonepine Capital Management, LLC 300,000$5,370,0003.16%
Palo Alto Investors LP 4,155,670$74,386,0003.13%
GREAT POINT PARTNERS LLC 497,531$8,906,0001.73%
Avoro Capital Advisors LLC 988,270$17,690,0001.37%
UNIVERSITY OF NOTRE DAME DU LAC 157,781$2,824,0000.79%
Birchview Capital, LP 68,000$1,217,0000.63%
Cheyne Capital Management (UK) LLP 74,000$1,323,0000.48%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 352,604$6,311,0000.43%
361 CAPITAL LLC 119,554$2,140,0000.41%
View complete list of VANDA PHARMACEUTICALS INC shareholders